Jingshan Jingyuan Technology Investment

Chairman and General Manager Li Jian holds sole investment authority, per Altss research. His operating background is rooted in the predecessor Jingshan Light Industry Machinery Factory, giving him technical as well as financial oversight. There is no public indication of an independent investment committee.

The real estate arm operates as a sibling entity under the broader group umbrella, developing mixed-use properties in Jingshan. Together with the J.S. Machine Industrial Park, it forms the asset-heavy foundation that likely generates recurring income to support venture allocations.

The firm executes direct equity investments and co-investment structures. Its known joint venture in Wuhan Zhongtaihe Finance Leasing, alongside Humanwell Healthcare, suggests an appetite for operating financial platforms beyond passive fund commitments.

Mandate spans seed, start-up, and expansion to late-stage venture, but specific concentration per stage is not publicly itemized. The broad range reflects a generalist approach rather than a stage-specialized fund strategy.

Co-investment relationships are central to its model. Beyond the Humanwell Healthcare leasing venture, Li Jian’s longstanding collaboration with Zall Group’s Yan Zhi indicates a willingness to partner with other industrialists on both commercial and investment initiatives.